While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

CEO Paul McKenzie announced a reaffirmation of guidance for fiscal 2025, targeting NPATA growth of 10% to 13%. He highlighted strong results from CSL Behring and growth in CSL Vifor, while ...

Reaffirmed FY25 NPATA guidance of $3.2 billion to $3.3 billion at constant currency, representing year-on-year growth of ...

The study shows that 94% of patients eliminated factor IX prophylaxis and maintained near-normal factor IX levels through ...

Hemgenix maintained factor IX levels at 37.4 IU/dL in year four, with a 90% reduction in annualized bleeding rates compared to baseline. At year four, 94% of patients remained off continuous ...

Read full article: Want to bring low-spend January into the rest of the year? Start by owning your Microsoft apps FILE - ...

Investing.com -- Global biotechnology leader CSL Behring (ASX:CSL; USOTC: CSLLY (OTC:CSLLY)) announced the four-year results from the HOPE-B study, confirming the long-term efficacy and safety of ...

Officials with John Muir Health have unveiled a planned expansion to the health care organization’s Walnut Creek facilities, following a hefty donation from the Behring Global Education Foundation.

Or was it 1974? By Laurie Gwen Shapiro One morning in the mid-1970s, a solemn announcement came over the intercom at Friends Seminary: “Noted person John Lennon is now in the meetinghouse.